Product Categories
| Country: | China |
|---|---|
| Tel: | 0531-88723173 |
| Mobile: | 18596073690 |
| E-mail: | 1047208234@qq.com |
| QQ: | 1047208234 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 2-tert-butylamine-1-(4-chlorophenyl)ethanol | C12H18ClNO | 14185-28-5 | Details |
| 1,2,3,5-tetrabromobenzene | C6H2Br4 | 634-89-9 | Details |
| (1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 2-(2-fluoro-[1,1'-biphenyl]-4-yl)propionate | Details |
| Impurity G (epiclindamycin palmitate) | Details |
| Roxithromycin EP Impurity B | C33H62N2O12 | 214902-82-6 | Details |
| Moxifloxacin hydrochloride racemic body | C21H25ClFN3O4 | 1346603-25-5 | Details |
| Apixaban Impurity C | C26H27N5O4 | 1686149-74-5 | Details |
| Epalrestat DiMer | Details |
| Hydrochloric acid determines nidalone impurity C | C32H46N2O7S2 | 141626-57-5 | Details |
| Chloropropyl Adenine | C8H10ClN5 | 50615-40-2 | Details |
| Boc-Tyr(tBu)-Aib-Glu(tBu)-Gly-OH | 2682040-93-1 | Details |
| N-Nitroso isoproterenol | Details |
| JTJ-2-1 | C6H12O2 | 21856-89-3 | Details |
| 3,4-dihydroxystyrene | C8H8O2 | 6053-02-7 | Details |
| Leborei impurity IV-1 | C17H19FN2O2 | 3037659-15-4 | Details |
| Tenofovir Impurity P0Z18 | Details |
| 4-Phenylbutyric acid-2-[ 2,3-bis-(4-phenylbutyryloxy)propoxy]-3-(4-phenylbutyryloxy)propyl ester | Details |
| Amanisometer3 | Details |
| 2,4-Dichloro-5-fluoro-6-methylpyrimidine | C5H3Cl2FN2 | 954220-98-5 | Details |
| Parecoxib Impurity 17 | C32H25N3O6S2 | 1373038-60-8 | Details |
| N-methyl-2-[[3-[(1E)-2-(2-pyridyl)vinyl]-1-[2-(2-pyridine)ethyl]-1H-indazole-6-yl]thiobenzamide | C29H25N5OS | 1443118-72-6 | Details |
| Revefenacin Impurity | C29H31N3O4 | 864760-28-1 | Details |
| 1-aldehyde-1,4,7,10-tetraazacyclodadecane | C9H20N4O | 120041-13-6 | Details |
| Indobufen Impurity 21 | C10H12N2 | 15494-55-0 | Details |
| (E)-oct-4-olemidioate ditert-butyl | C16H28O4 | 53432-90-9 | Details |
| (Z)-oct-4-en-1,8-diacid | C8H12O4 | 38561-68-1 | Details |
| 2-(2-hydroxyethoxy)-N,N,N-trimethyl-1-ammonium chloride (iodine ionic form | 41830-55-1 | Details |
| 4-acetamido-2-acetyloxy-benzoic acid | C11H11NO5 | 51-00-3 | Details |
| Afatinib maleate impurities HC1308-323 | Details |
| (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 2-((2-(2-fluoro-[1,1'-biphenyl]-4-yl)propionyl)oxy)propionate | Details |
| (S)-N-(2-amino-4-chloro-3-methylphenyl)-2-methylpyrrolidin-2-formamide | Details |
| 2-[(1S.5R)-3-ethylbicyclic [3.2.0]hepta-3-en-6-isounit]tert-butyl acetate | Details |
| IMP G | C13H18N4O3 | 93079-86-8 | Details |
| Ziprasidone Impurity G | C21H21ClN4O2S | 188797-76-4 | Details |
| N-Isopropylnortropine | C10H19NO | 3423-25-4 | Details |
| Gadobutrol Impurity A | C20H41ClN4O10 | 2514736-59-3 | Details |
| Cefuroxime ester oxide | C20H22N4O11S | 136235-54-6 | Details |
| BML/M2 impurity A | C12H17NO4 | 2767341-19-3 | Details |
| Velicitanidine formamide impurities | C18H14F2N8O | 2755814-39-0 | Details |
| 7-AVCA open-loop impurities | Details |
| Nicardipine Nitroso Impurity Z11-2 | Details |
| 2-(acetylamino)-5-hydroxybenzoic acid | C9H9NO4 | 1882-76-4 | Details |
| Plugliptin impurity RL103-2 | C10H18N2O4 | 109384-24-9 | Details |
| 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, tetrakis(1,1-diMethylethyl) ester | C32H60N4O8 | 585531-74-4 | Details |
| Tofacitinib citrate impurities VI | C16H19ClN6O | 1616761-00-2 | Details |
| Cetirizine Hydrochloride Impurity F (USP) | C21H25ClN2O3 | 1232460-31-9 | Details |
| Cefuroxime axetil dimer | C36H38N8O17S2 | 1202925-10-7 | Details |
| 3-(2,5-Dihydroxyphenyl)acrylic acid | C9H8O4 | 636-01-1 | Details |
| 2,4,6-triisopropylphenol | C15H24O | ‘2934-07-8 | Details |
| n-(2,4-dichloro-5-methoxyphenyl)acetamide | C9H9Cl2NO2 | 65182-98-1 | Details |
| HC121-3011 | C7H5ClF3N | 62476-58-8 | Details |
| XT-E Impurity 2 | Details |
| 2-Chloroethyl ethyl ether | C4H9ClO | 628-34-2 | Details |
| N,N'-Diethylethylenediamine | C6H16N2 | 111-74-0 | Details |
| N-Nitroso Acarbose | Details |
| Roxastat HD1701-3138 | Details |
| (1S.5R.6RS)-6-(nitromethyl)-3-ethyldicyclic [3.2.0]heptane-3-en-6-acetate tert-butyl ester | Details |
| (S)-(2-(2H-benzo[d][1,2,3]triazole-2-yl)-5-methoxyphenyl)(2-(5-chloro-4-methyl-1H-benzo[d]imidazo-2-yl)-2-methylpyrrolidin-1-yl)methyl ketone | Details |
| Compound J enantiomer | C20H16F2N4O3 | 1425767-92-5 | Details |
| Micuronium chloride (1R,2S)-Intermediate II. | C25H36NO6+ | 791546-70-8 | Details |
| Posaconazole Impurity 33 | C12H13F2IO2 | 182210-71-5 | Details |
| 3-Deoxyglucosone | C6H10O5 | 4084-27-9 | Details |
| Quintozene | C6Cl5NO2 | 82-68-8 | Details |
| Coenzyme Q7 (impurity B) | C44H66O4 | 303-95-7 | Details |
| Roxithromycin Z1 impurity C | Details |
| (R)-1-aMino-3-Methylbutylboronic acid | C5H14BNO2 | 389799-97-7 | Details |
| Agaquban SM1-2 | C9H17NO2 | 79199-62-5 | Details |
| 5-Methoxyisophthalic acid | C9H8O5 | 46331-50-4 | Details |
| Rivaroxaban Imp X | C10H12N2O2 | 19532-98-0 | Details |
| Roxithromycin EP Impurity J | C40H73ClN2O14 | 134834-12-1 | Details |
| C16H32N4O9 | 1793053-90-3 | Details |
| Fmoc-Aph(Cbm)-OH control | C25H23N3O5 | 324017-23-4 | Details |
| H-D-Aph (Cbm)-OH control | C10H13N3O3 | 1808153-79-8 | Details |
| Micuronium chloride (1R,2R)-Intermediate II. | C25H36ClNO6 | 107740-64-7 | Details |
| Agaquban SM1 | C9H17NO2 | 74892-82-3 | Details |
| (2R,3aS,7aS)-Octahydro-1H-indole-2-carboxylic acid | C9H15NO2 | 145513-91-3 | Details |
| C26H50N6O15 | 197909-67-4 | Details |
| Tamsulosin hydrochloride SM2 impurity G control | C10H14O3 | 3250-73-5 | Details |
| (1R,5S)-3-ethyl-Bicyclo[3.2.0]hept-3-en-6-one | C9H12O | 1235479-61-4 | Details |
| Mebeverine hydrochloride SM2-C | C11H14O2 | 16882-23-8 | Details |
| (1R,5S)-6-(nitromethyl)-3-ethylbicycl[3.2.0]heptane-3-en-6-tert-butyl acetate | Details |
| VST-04 (Valsartan Impurities USP-E) | C25H31N5O3 | 137863-17-3 | Details |
| Atomoxetine Hydrochloride Racemate | C17H22ClNO | 82857-40-7 | Details |
| Chlorpheniramine maleate salt | C20H23ClN2O4 | 2438-32-6 | Details |
| Fmoc-L-Thr(tBu)-Phe-OH | C32H36N2O6 | 1962160-86-6 | Details |
| Indobufen Impurity 20 | C10H12N2O3 | 858006-96-9 | Details |
| (S)-12-((R)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-7-hydroxy-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione | Details |
| Abemaciclib impurity C | Details |
| N-ethyl-N-(2-(ethylamino)ethyl)nitrosamine (SM2-10) | C6H15N3O | 29104-68-5 | Details |
| (R)-5-chloro-4-methyl-2-(2-methylpyrrolidin-2-yl)-1H-benzo[d]imidazole | Details |
| Sulbenicillin Impurity D | Details |
| Roxithromycin Z1 impurity B | Details |
| Sulfonicillin impurities J | Details |
| Drotaverine hydrochloride | C24H32ClNO4 | 985-12-6 | Details |
| Agaquban SM1-3 | C9H17NO2 | 78306-52-2 | Details |
| Torasemide Impurity M | C13H13N3O2S | 947327-54-0 | Details |
| 2-((Tert-butoxycarbonyl)amino)acrylic acid | C8H13NO4 | 45101-25-5 | Details |
| tert-butyl 2-((1R,5S)-3-ethylbicyclo[3.2.0]hept-3-en-6-ylidene)acetate | C15H22O2 | 1469800-26-7 | Details |
| Testosterone acetate | C21H30O3 | 1045-69-8 | Details |
| β-Tocotrienol | C28H42O2 | 490-23-3 | Details |
| Product Total： Product Page： | ||||
| 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 | ||||